Parkinson's disease (PD) is classically characterized by motor symptoms; however, non-motor symptoms (NMS) are increasingly recognized as relevant in disease-state, given the associated alterations in mood (depression and anxiety) and cognition. Here, particularly in regards to NMS, we aimed to compare the motor, emotional and cognitive behavior of three animal models of PD that trigger dopaminergic (DAergic) degeneration on both brain hemispheres: (i) the 6-hydroxydopamine (6-OHDA, 8 or 6 µg) lesion model; (ii) the paraquat (PQ) induced model, and (iii) a genetic model based on a-synuclein overexpression (a-syn). 6-OHDA and a-syn vector were injected bilaterally in the substantia nigra pars compacta (SNpc) of adult male Wistar rats; as for...
Parkinson’s disease (PD) is neurodegenerative disorder characterized by dopaminergic neuronal loss i...
The knowledge about the biochemical and behavioral changes in humans with PD has allowed proposing a...
The classical animal models of Parkinson’s disease (PD) rely on the use of neurotoxins, including 1-...
Parkinson\u27s disease (PD) is classically characterized by motor symptoms; however, non-motor sympt...
Parkinson\u27s disease (PD) is classically characterized by motor symptoms; however, non-motor sympt...
Parkinson's disease (PD) is classically characterized by motor symptoms; however, non-motor mani...
To investigate the psychiatric symptoms accompanying the early phases of Parkinson's disease (PD), w...
BACKGROUND: Parkinson's disease (PD) is a chronic neurodegenerative condition that is characterize...
Parkinson’s disease (PD) is a common neurodegenerative disorder, typically characterized by the pro...
Parkinson’s disease (PD) has for decades been considered a pure motor disorder and its cardinal moto...
Animal models of Parkinson's disease (PD) have proved highly effective in the discovery of novel tre...
A major pathological hallmark of Parkinson’s disease (PD) is a severe degeneration of dopamine (DA)-...
International audienceParkinson’s disease (PD) is associated with a large burden of non-motor sympto...
Development of relevant models of Parkinson's disease (PD) is essential for a better understanding o...
Early diagnosis of Parkinson’s disease (PD) offers perhaps, the most promising route to a successful...
Parkinson’s disease (PD) is neurodegenerative disorder characterized by dopaminergic neuronal loss i...
The knowledge about the biochemical and behavioral changes in humans with PD has allowed proposing a...
The classical animal models of Parkinson’s disease (PD) rely on the use of neurotoxins, including 1-...
Parkinson\u27s disease (PD) is classically characterized by motor symptoms; however, non-motor sympt...
Parkinson\u27s disease (PD) is classically characterized by motor symptoms; however, non-motor sympt...
Parkinson's disease (PD) is classically characterized by motor symptoms; however, non-motor mani...
To investigate the psychiatric symptoms accompanying the early phases of Parkinson's disease (PD), w...
BACKGROUND: Parkinson's disease (PD) is a chronic neurodegenerative condition that is characterize...
Parkinson’s disease (PD) is a common neurodegenerative disorder, typically characterized by the pro...
Parkinson’s disease (PD) has for decades been considered a pure motor disorder and its cardinal moto...
Animal models of Parkinson's disease (PD) have proved highly effective in the discovery of novel tre...
A major pathological hallmark of Parkinson’s disease (PD) is a severe degeneration of dopamine (DA)-...
International audienceParkinson’s disease (PD) is associated with a large burden of non-motor sympto...
Development of relevant models of Parkinson's disease (PD) is essential for a better understanding o...
Early diagnosis of Parkinson’s disease (PD) offers perhaps, the most promising route to a successful...
Parkinson’s disease (PD) is neurodegenerative disorder characterized by dopaminergic neuronal loss i...
The knowledge about the biochemical and behavioral changes in humans with PD has allowed proposing a...
The classical animal models of Parkinson’s disease (PD) rely on the use of neurotoxins, including 1-...